1Wan S, Leclerc JL, Vincent JL. Inflammatory response to cardiopulmonay bypass:machanisms involved and possible therapeutic strategies. Chest, 1997,112 : 676-692. 被引量：1
2Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins and serum amyloid A proteins. Adv Immunol, 1983,34:141-212. 被引量：1
3Manreen H, Anne O. Biologic properties of Interleukin-10. Immunology Today, 1992,13 : 198-200. 被引量：1
4Eppinger MJ, Ward PA, Bolling SF, et al. Regulatory effects of IL-10 on lung ischemic-reperfusion injury. J Thorac Cardiovasc Surg, 1996,112 : 1301-1306. 被引量：1
5Ferrer TJ, Webb JW,Wallace BH, et al. Interleukin-10 reduces morbidity and mortalits in murine multiple organ dysfunction syndrome (MODS). J Surg Research, 1998,77 : 157-164,. 被引量：1
6Klava A. Interleukin-10: A role in the development of postoperative immuno-supression. Arch Surg, 1997, 132:425-429. 被引量：1
7McBride WT, Armstrong AD, Crockard TJ, et al. Cytokine balance and immunsuppressive changes at cardiac surgery:contrasting responses between patients and isolated CPB cricus. Br J Anaesth, 1995,75 : 724-733. 被引量：1
8Tarbadel Y, Duchateau J, Schmartz D, et al. Corticosteriods increase blood interleukin-10 levels during cardiopulmonary bypass in man. Surgery, 1996,119 : 76-80. 被引量：1
